Dr Benjamin Trist

Dr Benjamin Trist, Early Career Researcher, The University of Sydney.

Benjamin is a multidisciplinary scientist working at the interface between the chemical and neurological sciences. He is an early career researcher at the Brain and Mind Centre within the University of Sydney, whose research utilises molecular biology and advanced analytical chemistry to elucidate biochemical mechanisms underlying neurological diseases including Parkinson’s disease and amyotrophic lateral sclerosis. Benjamin’s work to date has been published in some of the top journals within his field and his contribution to advancing our understanding of neurological diseases has been recognised by multiple individual awards from his research institution, as well as prominent patient advocacy bodies and national scientific societies. In addition, Benjamin actively engages with the public through neuroscience outreach programs and neurological disease patient support groups. Benjamin supervises honours and doctoral candidates at his institution and serves on multiple committees tasked with supporting early career researchers, and organising national scientific conferences.

Forefront Group:

  • BMC Neurogeneration Lab Motor Neuron Disease Research Group
  • BMC Neurodegeneration Lab Parkinson's Disease Research Group

Affiliate Organisations

The University of Sydney

Neurodegeneration of interest:

Parkinson’s disease, Motor Neuron Disease, Aging


  • Neuropathology
  • Analytical chemistry
  • Molecular biology

Specific Skills:

  • Human and murine post-mortem tissue work
  • Tissue sectioning
  • Immunohistochemistry
  • Brightfield and fluorescence microscopy
  • Immunoprecipitation
  • Gel-electrophoresis
  • Spectrophotometry
  • Mass spectrometry (ICP-MS, LA-ICP-MS, LC-MS/MS, FT-ICR-MS)


  • Is nerve cell death in Parkinson disease triggered by copper deficiency?
  • Is nerve cell death in amyotrophic lateral sclerosis (ALS) triggered by copper deficiency?